| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 45 | 2018 | 760 | 3.110 |
Why?
|
| Antibodies, Antinuclear | 27 | 2014 | 95 | 3.010 |
Why?
|
| Immunoglobulin Variable Region | 42 | 2018 | 110 | 2.590 |
Why?
|
| Immunoglobulin kappa-Chains | 33 | 2011 | 92 | 1.790 |
Why?
|
| Immunoglobulin Light Chains | 28 | 2014 | 91 | 1.700 |
Why?
|
| Immunoglobulin Heavy Chains | 40 | 2014 | 129 | 1.690 |
Why?
|
| Receptors, Antigen, B-Cell | 13 | 2012 | 108 | 1.660 |
Why?
|
| Genes, Immunoglobulin | 19 | 2012 | 111 | 1.600 |
Why?
|
| Autoantibodies | 16 | 2018 | 281 | 1.470 |
Why?
|
| Autoimmunity | 9 | 2011 | 192 | 1.410 |
Why?
|
| DNA | 28 | 2014 | 1327 | 1.270 |
Why?
|
| Immune Tolerance | 14 | 2022 | 385 | 1.090 |
Why?
|
| Lupus Erythematosus, Systemic | 9 | 2018 | 235 | 1.070 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 10 | 2008 | 24 | 1.050 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 11 | 2011 | 37 | 1.020 |
Why?
|
| Mice, Transgenic | 31 | 2019 | 1645 | 0.920 |
Why?
|
| Hybridomas | 29 | 2013 | 75 | 0.840 |
Why?
|
| Mice | 100 | 2019 | 12537 | 0.810 |
Why?
|
| Base Sequence | 41 | 2013 | 2342 | 0.800 |
Why?
|
| Microscopy, Electron | 1 | 2024 | 488 | 0.800 |
Why?
|
| Molecular Sequence Data | 36 | 2014 | 3040 | 0.750 |
Why?
|
| Complementarity Determining Regions | 4 | 2014 | 25 | 0.740 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2024 | 630 | 0.700 |
Why?
|
| Software | 2 | 2024 | 698 | 0.700 |
Why?
|
| Immunoglobulin Class Switching | 3 | 2018 | 40 | 0.690 |
Why?
|
| Amino Acid Sequence | 40 | 2014 | 2090 | 0.650 |
Why?
|
| Hemagglutinins, Viral | 6 | 2008 | 38 | 0.640 |
Why?
|
| Autoantigens | 10 | 2018 | 139 | 0.640 |
Why?
|
| B-Lymphocyte Subsets | 4 | 2011 | 42 | 0.620 |
Why?
|
| Animals | 108 | 2019 | 28889 | 0.610 |
Why?
|
| Mice, Inbred BALB C | 30 | 2011 | 1124 | 0.590 |
Why?
|
| Binding Sites, Antibody | 18 | 2006 | 50 | 0.520 |
Why?
|
| Epitopes | 11 | 2018 | 258 | 0.510 |
Why?
|
| Antibody Specificity | 17 | 2014 | 128 | 0.500 |
Why?
|
| Immunoglobulin M | 10 | 2013 | 164 | 0.480 |
Why?
|
| Rheumatoid Factor | 10 | 1997 | 26 | 0.470 |
Why?
|
| Antibodies, Viral | 5 | 2008 | 348 | 0.470 |
Why?
|
| Antibodies, Monoclonal | 13 | 2008 | 1425 | 0.430 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 4 | 2003 | 21 | 0.430 |
Why?
|
| Models, Immunological | 7 | 2005 | 85 | 0.410 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2024 | 1319 | 0.410 |
Why?
|
| Immunoglobulin G | 11 | 2003 | 481 | 0.390 |
Why?
|
| Mutation | 17 | 2015 | 4374 | 0.370 |
Why?
|
| Autoimmune Diseases | 9 | 2004 | 257 | 0.370 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 2 | 2011 | 35 | 0.360 |
Why?
|
| Antibody Formation | 4 | 2007 | 181 | 0.350 |
Why?
|
| DNA, Single-Stranded | 5 | 1999 | 97 | 0.350 |
Why?
|
| RNA Editing | 3 | 2006 | 48 | 0.340 |
Why?
|
| Immunoglobulin lambda-Chains | 9 | 2004 | 39 | 0.340 |
Why?
|
| Antibody Diversity | 11 | 2007 | 25 | 0.320 |
Why?
|
| Recombination, Genetic | 17 | 2002 | 444 | 0.290 |
Why?
|
| Spleen | 7 | 2006 | 420 | 0.280 |
Why?
|
| Self Tolerance | 5 | 2014 | 27 | 0.280 |
Why?
|
| Precursor Cells, B-Lymphoid | 2 | 2022 | 27 | 0.270 |
Why?
|
| Mice, Inbred MRL lpr | 6 | 2011 | 37 | 0.260 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2008 | 115 | 0.260 |
Why?
|
| Phosphatidylserines | 3 | 2008 | 21 | 0.260 |
Why?
|
| Immunoglobulin Idiotypes | 4 | 1992 | 12 | 0.250 |
Why?
|
| Graft vs Host Reaction | 1 | 2006 | 14 | 0.250 |
Why?
|
| Apoptosis | 5 | 2022 | 1756 | 0.250 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2003 | 10 | 0.240 |
Why?
|
| Immunologic Memory | 5 | 2018 | 188 | 0.240 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2014 | 422 | 0.230 |
Why?
|
| Alleles | 13 | 2006 | 1157 | 0.230 |
Why?
|
| Genome, Viral | 1 | 2005 | 80 | 0.220 |
Why?
|
| Bone Marrow | 2 | 2023 | 415 | 0.220 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2005 | 96 | 0.220 |
Why?
|
| Data Collection | 1 | 2006 | 381 | 0.220 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 443 | 0.210 |
Why?
|
| Gene Rearrangement | 4 | 2006 | 179 | 0.210 |
Why?
|
| Spatial Analysis | 1 | 2024 | 10 | 0.210 |
Why?
|
| Myeloma Proteins | 20 | 1981 | 39 | 0.210 |
Why?
|
| Immunoglobulin Joining Region | 3 | 2000 | 13 | 0.210 |
Why?
|
| Influenza A virus | 3 | 1991 | 177 | 0.210 |
Why?
|
| Cell Nucleus | 4 | 2023 | 618 | 0.210 |
Why?
|
| Genes | 15 | 1986 | 307 | 0.200 |
Why?
|
| Organelles | 1 | 2024 | 58 | 0.200 |
Why?
|
| Cell Differentiation | 6 | 2007 | 1662 | 0.200 |
Why?
|
| Flow Cytometry | 7 | 2012 | 726 | 0.200 |
Why?
|
| Models, Molecular | 9 | 2013 | 1375 | 0.200 |
Why?
|
| Phenotype | 2 | 2012 | 2575 | 0.190 |
Why?
|
| Hematology | 1 | 2023 | 31 | 0.190 |
Why?
|
| Glycosaminoglycans | 2 | 2013 | 49 | 0.190 |
Why?
|
| Blotting, Southern | 8 | 1994 | 126 | 0.180 |
Why?
|
| Golgi Apparatus | 2 | 2013 | 116 | 0.180 |
Why?
|
| Isoantigens | 1 | 2002 | 72 | 0.180 |
Why?
|
| Humans | 32 | 2024 | 95800 | 0.170 |
Why?
|
| Sequence Alignment | 4 | 2006 | 360 | 0.170 |
Why?
|
| snRNP Core Proteins | 2 | 2018 | 9 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2004 | 282 | 0.170 |
Why?
|
| Antibodies, Anti-Idiotypic | 3 | 1990 | 44 | 0.160 |
Why?
|
| Transgenes | 5 | 2007 | 186 | 0.160 |
Why?
|
| Antibody Affinity | 3 | 2014 | 38 | 0.160 |
Why?
|
| Algorithms | 4 | 2023 | 2015 | 0.160 |
Why?
|
| Genome, Human | 1 | 2005 | 824 | 0.160 |
Why?
|
| Mice, Inbred Strains | 11 | 2002 | 297 | 0.160 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2019 | 11 | 0.160 |
Why?
|
| Plasmacytoma | 10 | 1987 | 34 | 0.160 |
Why?
|
| Genetic Linkage | 6 | 1989 | 620 | 0.150 |
Why?
|
| Contrast Sensitivity | 1 | 2019 | 72 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 5 | 2016 | 930 | 0.150 |
Why?
|
| DNA-Binding Proteins | 3 | 2002 | 1267 | 0.150 |
Why?
|
| Immunoglobulin Fragments | 7 | 2009 | 23 | 0.150 |
Why?
|
| Motion Perception | 1 | 2019 | 107 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 11 | 2019 | 3491 | 0.140 |
Why?
|
| Cell Line | 7 | 2011 | 2536 | 0.140 |
Why?
|
| DNA Repair Enzymes | 1 | 1998 | 61 | 0.130 |
Why?
|
| Mice, Mutant Strains | 8 | 2002 | 232 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 1 | 1998 | 155 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 220 | 0.130 |
Why?
|
| Genetic Markers | 1 | 2018 | 477 | 0.130 |
Why?
|
| Central Tolerance | 1 | 2016 | 8 | 0.130 |
Why?
|
| Models, Genetic | 5 | 2005 | 984 | 0.120 |
Why?
|
| Protein Conformation | 4 | 2013 | 935 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2013 | 326 | 0.120 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 2061 | 0.120 |
Why?
|
| Pericytes | 1 | 2016 | 14 | 0.120 |
Why?
|
| Lymphoma | 2 | 1989 | 253 | 0.120 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 145 | 0.120 |
Why?
|
| DNA Repair | 1 | 1998 | 376 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2016 | 172 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1275 | 0.120 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2015 | 9 | 0.120 |
Why?
|
| T-Lymphocytes | 2 | 2016 | 1310 | 0.110 |
Why?
|
| Cell Communication | 1 | 2016 | 221 | 0.110 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1994 | 20 | 0.110 |
Why?
|
| Sumoylation | 1 | 2014 | 19 | 0.110 |
Why?
|
| Microscopy | 1 | 2015 | 90 | 0.110 |
Why?
|
| Paraproteinemias | 1 | 2014 | 19 | 0.110 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 46 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2012 | 380 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2015 | 153 | 0.110 |
Why?
|
| Clonal Deletion | 1 | 1994 | 23 | 0.100 |
Why?
|
| Proteins | 2 | 1998 | 816 | 0.100 |
Why?
|
| Wound Healing | 1 | 2016 | 378 | 0.100 |
Why?
|
| DNA Primers | 3 | 2004 | 548 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2016 | 477 | 0.100 |
Why?
|
| Dextrans | 6 | 1980 | 78 | 0.100 |
Why?
|
| Receptors, Immunologic | 2 | 2007 | 142 | 0.100 |
Why?
|
| Gene Expression | 3 | 2012 | 1319 | 0.100 |
Why?
|
| Bone Marrow Cells | 4 | 2023 | 270 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 297 | 0.090 |
Why?
|
| Immunization, Passive | 1 | 2011 | 75 | 0.090 |
Why?
|
| Immune Complex Diseases | 1 | 2011 | 20 | 0.090 |
Why?
|
| HIV Antibodies | 1 | 2011 | 39 | 0.090 |
Why?
|
| Restriction Mapping | 4 | 1993 | 152 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1957 | 0.090 |
Why?
|
| Lymphocyte Activation | 6 | 2016 | 810 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 89 | 0.090 |
Why?
|
| Mice, Inbred A | 1 | 2011 | 23 | 0.090 |
Why?
|
| Cross Reactions | 5 | 2004 | 115 | 0.090 |
Why?
|
| Models, Biological | 2 | 2016 | 1809 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2011 | 2161 | 0.080 |
Why?
|
| Lymphopenia | 1 | 2011 | 31 | 0.080 |
Why?
|
| Translocation, Genetic | 3 | 1987 | 250 | 0.080 |
Why?
|
| Aging | 2 | 2015 | 766 | 0.080 |
Why?
|
| Genes, Switch | 1 | 1990 | 8 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 163 | 0.080 |
Why?
|
| Genes, Regulator | 1 | 1990 | 65 | 0.080 |
Why?
|
| Cloning, Molecular | 5 | 1994 | 648 | 0.080 |
Why?
|
| Orthomyxoviridae | 1 | 1990 | 48 | 0.080 |
Why?
|
| Immunoglobulin Isotypes | 3 | 2002 | 33 | 0.080 |
Why?
|
| Graft vs Host Disease | 2 | 2003 | 368 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2011 | 260 | 0.080 |
Why?
|
| Immunoglobulins | 5 | 1982 | 144 | 0.080 |
Why?
|
| Computer Simulation | 4 | 2019 | 1158 | 0.070 |
Why?
|
| Indoles | 2 | 2012 | 317 | 0.070 |
Why?
|
| Multigene Family | 1 | 1989 | 213 | 0.070 |
Why?
|
| Female | 13 | 2019 | 49872 | 0.070 |
Why?
|
| Antibodies | 4 | 1980 | 356 | 0.070 |
Why?
|
| Immunoglobulin Allotypes | 3 | 2003 | 5 | 0.060 |
Why?
|
| Clone Cells | 4 | 1998 | 223 | 0.060 |
Why?
|
| Immune System | 1 | 2007 | 103 | 0.060 |
Why?
|
| Immunoglobulin Subunits | 1 | 2006 | 2 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2009 | 687 | 0.060 |
Why?
|
| Lymphocyte Count | 1 | 2006 | 102 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2006 | 983 | 0.060 |
Why?
|
| Histocompatibility Antigens | 1 | 2005 | 37 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 113 | 0.060 |
Why?
|
| Antigens, Viral | 1 | 2005 | 135 | 0.060 |
Why?
|
| United States | 1 | 2018 | 7764 | 0.050 |
Why?
|
| Mice, Inbred NZB | 7 | 1982 | 13 | 0.050 |
Why?
|
| Lipopolysaccharides | 4 | 2006 | 305 | 0.050 |
Why?
|
| Transcription, Genetic | 4 | 1991 | 1192 | 0.050 |
Why?
|
| Immunoglobulin D | 1 | 2004 | 3 | 0.050 |
Why?
|
| Immunomagnetic Separation | 1 | 2004 | 8 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 632 | 0.050 |
Why?
|
| Arginine | 2 | 1995 | 144 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 69 | 0.050 |
Why?
|
| Histological Techniques | 1 | 2023 | 35 | 0.050 |
Why?
|
| Monte Carlo Method | 2 | 2009 | 191 | 0.050 |
Why?
|
| Species Specificity | 6 | 1990 | 707 | 0.050 |
Why?
|
| Animals, Congenic | 1 | 2003 | 1 | 0.050 |
Why?
|
| Peptides | 2 | 2005 | 671 | 0.050 |
Why?
|
| Bone Marrow Examination | 1 | 2023 | 41 | 0.050 |
Why?
|
| Static Electricity | 1 | 2003 | 97 | 0.050 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2022 | 29 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2022 | 36 | 0.050 |
Why?
|
| Visual Perception | 1 | 2006 | 339 | 0.050 |
Why?
|
| RNA, Messenger | 5 | 1991 | 2089 | 0.050 |
Why?
|
| Crosses, Genetic | 6 | 2012 | 171 | 0.050 |
Why?
|
| Workflow | 1 | 2023 | 80 | 0.050 |
Why?
|
| HIV Infections | 1 | 2011 | 974 | 0.050 |
Why?
|
| Isoelectric Point | 1 | 2001 | 13 | 0.050 |
Why?
|
| Lysosomes | 1 | 2022 | 124 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 286 | 0.040 |
Why?
|
| Codon | 1 | 2001 | 120 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 149 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 185 | 0.040 |
Why?
|
| Transfection | 3 | 1994 | 908 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 1985 | 829 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2002 | 480 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 367 | 0.040 |
Why?
|
| Immunophenotyping | 3 | 2007 | 226 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2001 | 336 | 0.040 |
Why?
|
| Chromatin | 1 | 2004 | 444 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2001 | 231 | 0.040 |
Why?
|
| Retinal Bipolar Cells | 1 | 2019 | 5 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2001 | 302 | 0.040 |
Why?
|
| Haplotypes | 1 | 2002 | 650 | 0.040 |
Why?
|
| Rhodopsin | 1 | 2019 | 21 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 2777 | 0.040 |
Why?
|
| Scattering, Radiation | 1 | 2019 | 122 | 0.040 |
Why?
|
| Cardiolipins | 2 | 1991 | 17 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2882 | 0.040 |
Why?
|
| Immunoglobulin Switch Region | 2 | 1990 | 10 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2007 | 2473 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2019 | 74 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 281 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2002 | 594 | 0.040 |
Why?
|
| Light | 1 | 2019 | 297 | 0.040 |
Why?
|
| Liver | 3 | 1990 | 1231 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 750 | 0.040 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 1998 | 25 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1989 | 175 | 0.030 |
Why?
|
| Immunoglobulin J-Chains | 2 | 1987 | 12 | 0.030 |
Why?
|
| Thymocytes | 1 | 2016 | 31 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 1996 | 32 | 0.030 |
Why?
|
| Chromosome Mapping | 6 | 1985 | 1080 | 0.030 |
Why?
|
| Granulation Tissue | 1 | 2016 | 15 | 0.030 |
Why?
|
| Neoplasms, Experimental | 6 | 1983 | 270 | 0.030 |
Why?
|
| Dermis | 1 | 2016 | 30 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 212 | 0.030 |
Why?
|
| Deoxyribonucleoproteins | 1 | 1995 | 2 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 69 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 202 | 0.030 |
Why?
|
| Antigens, Ly | 2 | 1986 | 37 | 0.030 |
Why?
|
| Protein Aggregates | 1 | 2015 | 28 | 0.030 |
Why?
|
| Prealbumin | 1 | 1975 | 42 | 0.030 |
Why?
|
| Prions | 1 | 2015 | 52 | 0.030 |
Why?
|
| Jurkat Cells | 2 | 2008 | 84 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1975 | 127 | 0.030 |
Why?
|
| SUMO-1 Protein | 1 | 2014 | 16 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 299 | 0.030 |
Why?
|
| Computer Graphics | 1 | 2015 | 102 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1997 | 431 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1994 | 26 | 0.030 |
Why?
|
| Point Mutation | 1 | 1995 | 247 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2014 | 115 | 0.030 |
Why?
|
| Oligosaccharides | 2 | 1974 | 25 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2015 | 288 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 127 | 0.030 |
Why?
|
| Mice, Inbred C3H | 3 | 1987 | 372 | 0.030 |
Why?
|
| Genotype | 3 | 2006 | 1880 | 0.030 |
Why?
|
| Haptens | 4 | 1979 | 10 | 0.030 |
Why?
|
| Immunoglobulin Constant Regions | 2 | 1985 | 21 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 564 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 382 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1993 | 60 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2014 | 215 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 489 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 64 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 1993 | 435 | 0.020 |
Why?
|
| Immunoassay | 1 | 2013 | 100 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 131 | 0.020 |
Why?
|
| Pedigree | 1 | 2014 | 977 | 0.020 |
Why?
|
| Immunogenetics | 1 | 1972 | 8 | 0.020 |
Why?
|
| Clodronic Acid | 1 | 2012 | 9 | 0.020 |
Why?
|
| Ligands | 2 | 2009 | 478 | 0.020 |
Why?
|
| Liposomes | 1 | 2012 | 99 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2012 | 77 | 0.020 |
Why?
|
| Male | 6 | 2019 | 45686 | 0.020 |
Why?
|
| Hemocyanins | 1 | 1991 | 8 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 2011 | 8 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1991 | 257 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 138 | 0.020 |
Why?
|
| Rabbits | 2 | 1984 | 639 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 92 | 0.020 |
Why?
|
| Binding, Competitive | 3 | 1984 | 147 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 279 | 0.020 |
Why?
|
| Kinetics | 2 | 1994 | 1561 | 0.020 |
Why?
|
| Viral Load | 1 | 2011 | 164 | 0.020 |
Why?
|
| Multiple Myeloma | 2 | 1979 | 353 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 1010 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 39 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 796 | 0.020 |
Why?
|
| Mice, Inbred AKR | 3 | 1980 | 10 | 0.020 |
Why?
|
| Radioimmunoassay | 2 | 1984 | 150 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1989 | 71 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2009 | 70 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1991 | 1008 | 0.020 |
Why?
|
| Immunoglobulin A | 4 | 1979 | 91 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 1989 | 156 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 503 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1991 | 1006 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 2 | 2002 | 291 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 2008 | 69 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1827 | 0.020 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 9 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2007 | 28 | 0.020 |
Why?
|
| Computers | 1 | 2007 | 109 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 1987 | 38 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2009 | 3581 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 1156 | 0.020 |
Why?
|
| Stem Cells | 1 | 1989 | 394 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1986 | 217 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1987 | 1046 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2005 | 16 | 0.010 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2005 | 9 | 0.010 |
Why?
|
| Stochastic Processes | 1 | 2005 | 79 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1985 | 97 | 0.010 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1985 | 83 | 0.010 |
Why?
|
| Genetic Code | 3 | 1974 | 26 | 0.010 |
Why?
|
| Time Factors | 2 | 2007 | 5561 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 28208 | 0.010 |
Why?
|
| Antigens | 2 | 2003 | 231 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 28578 | 0.010 |
Why?
|
| Binding Sites | 3 | 1978 | 1167 | 0.010 |
Why?
|
| Cell Division | 1 | 2005 | 701 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 5961 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1970 | 1422 | 0.010 |
Why?
|
| Hybrid Cells | 2 | 1981 | 71 | 0.010 |
Why?
|
| Chromosome Deletion | 2 | 1981 | 223 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 910 | 0.010 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2001 | 6 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 7026 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1981 | 15 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1981 | 38 | 0.010 |
Why?
|
| Nucleic Acid Precursors | 1 | 1980 | 3 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1980 | 62 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1980 | 89 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1980 | 57 | 0.010 |
Why?
|
| Rats | 1 | 1985 | 4154 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 1997 | 82 | 0.010 |
Why?
|
| Entropy | 1 | 1997 | 43 | 0.010 |
Why?
|
| Dimerization | 1 | 1997 | 150 | 0.010 |
Why?
|
| Erythrocytes | 2 | 1982 | 252 | 0.010 |
Why?
|
| Immunochemistry | 2 | 1974 | 18 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 20848 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1985 | 1030 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 1996 | 23 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 1996 | 175 | 0.010 |
Why?
|
| Isoantibodies | 1 | 1977 | 127 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1997 | 187 | 0.010 |
Why?
|
| Crossing Over, Genetic | 1 | 1975 | 34 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1975 | 149 | 0.010 |
Why?
|
| Autoanalysis | 1 | 1973 | 6 | 0.010 |
Why?
|
| Thermolysin | 1 | 1973 | 9 | 0.010 |
Why?
|
| Chromatography | 1 | 1973 | 28 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1973 | 54 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1973 | 28 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 394 | 0.010 |
Why?
|
| Trypsin | 1 | 1973 | 95 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1974 | 138 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1973 | 146 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1973 | 18 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1973 | 22 | 0.010 |
Why?
|
| Disaccharides | 1 | 1973 | 24 | 0.010 |
Why?
|
| Maltose | 1 | 1973 | 33 | 0.010 |
Why?
|
| Immune Sera | 1 | 1972 | 53 | 0.010 |
Why?
|
| Sheep | 1 | 1972 | 250 | 0.010 |
Why?
|
| Cryoglobulins | 1 | 1992 | 4 | 0.010 |
Why?
|
| Immunization | 1 | 1972 | 165 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1972 | 96 | 0.010 |
Why?
|
| Glomerulonephritis | 1 | 1992 | 80 | 0.010 |
Why?
|
| Syndrome | 1 | 1992 | 450 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1970 | 90 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1992 | 176 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1996 | 2534 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1978 | 241 | 0.000 |
Why?
|
| Selection, Genetic | 1 | 1970 | 537 | 0.000 |
Why?
|
| Animals, Wild | 1 | 1982 | 52 | 0.000 |
Why?
|
| Protein Binding | 2 | 1978 | 1560 | 0.000 |
Why?
|
| Gene Amplification | 1 | 1982 | 142 | 0.000 |
Why?
|
| Antilymphocyte Serum | 1 | 1982 | 69 | 0.000 |
Why?
|
| Coliphages | 1 | 1979 | 59 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1979 | 90 | 0.000 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1978 | 4 | 0.000 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1978 | 10 | 0.000 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1978 | 17 | 0.000 |
Why?
|
| Phosphorylcholine | 1 | 1978 | 27 | 0.000 |
Why?
|
| Nitrobenzenes | 1 | 1975 | 12 | 0.000 |
Why?
|
| Inulin | 1 | 1972 | 17 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1972 | 108 | 0.000 |
Why?
|
| Fructose | 1 | 1972 | 36 | 0.000 |
Why?
|
| Glucose | 1 | 1972 | 701 | 0.000 |
Why?
|